APA aipamena

Griffett, K., & Burris, T. P. (2016). Promiscuous activity of the LXR antagonist GSK2033 in a mouse model of fatty liver disease. Biochem Biophys Res Commun.

Chicago Style aipamena

Griffett, Kristine, and Thomas P. Burris. "Promiscuous Activity of the LXR Antagonist GSK2033 in a Mouse Model of Fatty Liver Disease." Biochem Biophys Res Commun 2016.

MLA aipamena

Griffett, Kristine, and Thomas P. Burris. "Promiscuous Activity of the LXR Antagonist GSK2033 in a Mouse Model of Fatty Liver Disease." Biochem Biophys Res Commun 2016.